A Mouse Model of Beta-Cell Dysfunction as Seen in Human Type 2 Diabetes
Loss of first-phase insulin release is an early pathogenic feature of type 2 diabetes (T2D). Various mouse models exist to study T2D; however, few recapitulate the early β-cell defects seen in humans. We sought to develop a nongenetic mouse model of T2D that exhibits reduced first-phase insulin secr...
Saved in:
| Main Authors: | Jacqueline H. Parilla, Joshua R. Willard, Breanne M. Barrow, Sakeneh Zraika |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2018/6106051 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
To Be Seen, or Not to Be Seen
by: John Sodiq Sanni
Published: (2025-05-01) -
Semaglutide ameliorates diabetes-associated cognitive dysfunction in mouse model of type 2 diabetes
by: Yan Zhu, et al.
Published: (2025-01-01) -
The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis.
by: Martijn van de Bunt, et al.
Published: (2013-01-01) -
Recombinant Human Thymosin Beta-4 Protects against Mouse Coronavirus Infection
by: Rui Yu, et al.
Published: (2021-01-01) -
Macrophage contact dependent and independent TLR4 mechanisms induce β-cell dysfunction and apoptosis in a mouse model of type 2 diabetes.
by: Helena Cucak, et al.
Published: (2014-01-01)